Phagelux (Canada) Inc.

Calculating rank

USPTO Granted Patents = 5

Forward Citations = 9

Loading Chart...

5 inventors (with patents filed for the assignee):

Nancy Tawil (5 out of 8 patents)

Ramaz Katsarava (5 out of 17 patents)

David Tugushi (5 out of 8 patents)

4. Vakhtang Beridze (5 out of 6 patents)

5. Edwige Caroline Rebecca Arnold (2 out of 2 patents)

5 patents: Sort by Forward Citations

1. 11684587 - Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof (2023-06-27),

2. 11564894 - Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof (2023-01-31),

3. 11413319 - Microencapsulation of bacteriophages and related products (2022-08-16),

4. 10849944 - Microencapsulation of bacteriophages and related products (2020-12-01),

5. 10772964 - Composition comprising a polymer and a bioactive agent and method of preparing thereof (2020-09-15),

Company Overview

Phagelux (Canada) Inc. is a biotechnology company dedicated to developing and commercializing bacteriophage-based products to control bacterial pathogens in various industries. Their innovative solutions provide safe and effective alternatives to traditional antimicrobial agents, with a focus on environmental sustainability and consumer safety. With a team of experts in phage technology, microbiology, and product development, Phagelux is at the forefront of the phage therapy revolution.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

5 Patents

#202 in Montreal

#2,859 in Canada

Montreal, Canada